banner

PHARMACEUTICAL & MEDICAL PACKAGING NEWS

  • email
  • twitter
  • linkedin
  • facebook
The Latest on Drug Master Files for Packaging Materials in the United States—And a Little History
Joan Sylvain Baughan and Cynthia Lieberman of Keller and Heckman LLP By Joan Sylvain Baughan and Cynthia Lieberman The U.S. FDA evaluates the...

Pharma and Medical Packaging Technologies on Display
Photo courtesy of Dara via NJM Packaging. NJM is the exclusive sales agent for Dara in the USA and Canada. Pharmaceutical and medical packaging...

UDI Gets Helping Hand From Serialization Solutions Provider
As medical device companies work to ensure compliance with Unique Device Identification, they’re still dealing with on-going tasks such as...

Determining a Valid Sample Size for Package Testing
A process for answering one of the most difficult questions in testing. By Brandon Muhlestein and Pal Khangaldy “How many packaging samples...

Serialization Validation: Start Early, Says Expert
Validation is a critical step in implementing serialization programs. Planning your validation approach early on can help you establish your...

What Does FDA's DSCSA Enforcement Delay Really Mean?
FDA is delaying enforcement of the upcoming product identifier requirement under the Drug Supply Chain Safety Act, but should this delay alter...

FDA Looks to Pilot Projects to Enhance Pharma Track-And-Trace
The U.S. Food and Drug Administration (FDA) is asking pharmaceutical packaging companies, brand owners and entities engaged at various levels of...

Preparing for Connected Health
Soligie Printed Electronics by Molex The "smartphone has created a paradigm shift in healthcare, and it is becoming a healthcare device,” says...

How Often Are You Auditing Your Own Operations?
Audits of quality systems are required in the medical device industry—but are you conducting your own internal audits on a routine basis? Are...

5 Benefits to Using Polymers for Primary Drug Containers
Pharmaceutical pipelines have been shifting for the last 20 years toward the development of biologics, which make up about 70% of drugs...